CEL-SCI Corporation news

   Watch this stock
Showing stories 61 - 70 of about 87   

Articles published

CVM 1.87 +0.07 (3.89%)
price chart
Tracking the one year Price Target on CEL-SCI Corporation (CVM)
Cel-Sci Corporation (NYSEMKT:CVM) stock ended the last trade transaction at $1.71. The 50-Day Moving Average price noticed at $1.79 and the 200 Day Moving Average price is at $1.21.
CEL-SCI CORP. NEW DL-,01 (LSRM) Declined -2.74% on Sep 30
Shares of CEL-SCI CORP. NEW DL-,01 (FRA:LSRM) last traded at 1.35, representing a move of -2.74%, or -0.04 per share, on volume of shares.
Vicente Benjamin Asuncion Sells 160000 Shares of Cvr Medical Corp (CVM) Stock
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system.
Cvr Medical Corp (CVM) Director Sells C$62400.00 in Stock
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system.
CEL-SCI Corporation (CVM) stock moved with rise of 3.98%
CEL-SCI Corporation (CVM) witnessed gain 3.98% in recent trading period with closing price of $1.83. The company's last traded volume of 0.25 million shares as compared to it's an average volume of 0.21 million shares.
CEL-SCI Corporation (CVM) stock price is worth at $1.71
CEL-SCI Corporation (CVM) stock added 3.01% beyond one week and declined -3.39% during previous one month session. The stock went down -25.97% at some stage in past quarter.
EPS for Ocera Therapeutics (OCRX) Expected At $-0.23; Cel Sci (NYSEAMERICAN ...
Cel Sci Corporation (NYSEAMERICAN:CVM) had a decrease of 17.07% in short interest. CVM's SI was 628,800 shares in October as released by FINRA.
West Nile Virus Infections – in-Depth Analysis, Forecasts, Applications ...
HTF Market Intelligence released a new research report of 67 pages on title 'West Nile Virus Infections - Pipeline Review, H1 2017' with detailed analysis, forecast and strategies.
West Nile Virus Infection Treatment Market – Global Industrial Applications ...
Leading players in the global WNV infection treatment market are Kineta Inc., Hemispherx Biophrma Inc., CEL-SCI Corporation, and Hawaii Biotech Inc. Each of the companies are profiled for key business attributes such as recent developments, financial ...
Cel-Sci Corporation (CVM) Under Analyst Spotlight
Cel-Sci Corporation has a 50 day moving average of 2.07 and a 200 day moving average of 1.07. The stock's market capitalization is 15.50M, it has a 52-week low of 1.46 and a 52-week high of 7.98.